Edition:
United Kingdom

Novavax Inc (NVAX.OQ)

NVAX.OQ on NASDAQ Stock Exchange Global Select Market

2.03USD
17 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.03
Open
$2.03
Day's High
$2.04
Day's Low
$1.96
Volume
754,161
Avg. Vol
1,235,850
52-wk High
$2.75
52-wk Low
$0.96

Latest Key Developments (Source: Significant Developments)

Novavax Q2 Loss Per Share $0.12
Wednesday, 8 Aug 2018 

Novavax Inc ::NOVAVAX REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.12.Q2 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S.Q2 REVENUE $10.8 MILLION VERSUS I/B/E/S VIEW $9.9 MILLION.PHASE 2 CLINICAL TRIAL OF QUADRIVALENT FORMULATIONS OF NANOFLU IS EXPECTED TO BEGIN IN Q3 OF 2018.TOP-LINE DATA FROM PHASE 2 CLINICAL TRIAL OF NANOFLU & END OF PHASE 2 MEETING WITH FDA EXPECTED IN Q1 2019.  Full Article

Novavax Q2 Loss Per Share $0.12
Wednesday, 8 Aug 2018 

Novavax Inc ::NOVAVAX REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.12.Q2 REVENUE $10.8 MILLION VERSUS I/B/E/S VIEW $9.9 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S.  Full Article

Novavax Prices Public Offering 30.3 Mln Common Shares At $1.65 Per Share
Thursday, 12 Apr 2018 

April 11 (Reuters) - Novavax Inc ::NOVAVAX PRICES PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 30.3 MILLION COMMON SHARES PRICED AT $1.65PER SHARE.SAYS PUBLIC OFFERING OF 30.3 MILLION COMMON SHARES PRICED AT $1.65PER SHARE.  Full Article

Novavax Announces Proposed Public Offering Of Common Stock
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Novavax Inc ::NOVAVAX ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Novavax Files Prospectus Supplement Related To Issuance, Sale Of Up To $75 Mln Of Common Stock
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Novavax Inc ::NOVAVAX INC FILES PROSPECTUS SUPPLEMENT RELATES TO THE ISSUANCE AND SALE OF UP TO $75 MILLION OF COMMON STOCK -SEC FILING‍​.  Full Article

Novavax CEO Stanley Erck reports open market purchase of 100,000 co's common shares
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Novavax Inc :Novavax Inc says CEO Stanley Erck reports open market purchase of 100,000 co's common shares at average price of $1.13per share on november 9 - sec filing.  Full Article

Novavax reports Q3 loss per share $0.15
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Novavax Inc ::Novavax reports third quarter 2017 financial results.Q3 loss per share $0.15.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Q3 revenue $8.4 million versus $3.2 million.Q3 revenue view $6.4 million -- Thomson Reuters I/B/E/S.  Full Article

Novavax Q3 loss per share $0.15
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Novavax Inc ::Novavax reports third quarter 2017 financial results.Q3 loss per share $0.15.Q3 revenue $8.4 million versus $3.2 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Q3 revenue view $6.4 million -- Thomson Reuters I/B/E/S.Novavax - ‍as of Sept 30, 2017, co had $172.6 million in cash, cash equivalents and marketable securities, compared to $235.5 million as of Dec 31, 2016​.  Full Article

Novavax announces leadership change
Friday, 13 Oct 2017 

Oct 13 (Reuters) - Novavax Inc ::Novavax announces leadership change.Novavax Inc - ‍Barclay Phillips has submitted his resignation as senior vice president, chief financial officer (CFO) and treasurer​.Novavax Inc - ‍Erck will act as interim CFO pending completion of a search for a new chief financial officer​.  Full Article

BRIEF-Novavax Q1 Loss Per Share $0.14

* Q1 EARNINGS PER SHARE VIEW $-0.13 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: